Ligand validation:7HIK

XJV: imidazolidin-2-one

XJV is a Ligand Of Interest in 7HIK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HIK_XJV_A_208	42%	94%	0.137	0.855	0.15	0.29	-	-	0	0	100%	0.52
7HIK_XJV_D_206	20%	94%	0.172	0.775	0.17	0.28	-	-	0	0	100%	0.52
7HIK_XJV_B_201	12%	93%	0.221	0.745	0.2	0.29	-	-	0	0	100%	0.52
7H8C_XJV_D_206	68%	93%	0.117	0.928	0.17	0.3	-	-	0	0	100%	0.68
5S81_XJV_B_507	55%	16%	0.136	0.905	1.95	1.76	3	2	0	0	100%	0.58

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.